{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T19:37:13Z","timestamp":1772912233403,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The effect of supplements on mortality risk in patients with cancer remains uncertain and has scarcely been investigated in subgroups of patients with varying characteristics. This study aimed to investigate the association between two popular supplements, fish oil and glucosamine, and mortality risk in a large population-based cohort and determine whether cardiovascular health and clinical prognosis influence these associations.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This prospective cohort study analyzed the data of UK Biobank participants who were diagnosed with cancer. The associations of fish oil and glucosamine consumption with mortality were analyzed using Cox proportional hazards models. Subgroup analyses were performed to assess the effects of Life Essential 8 [LE8] scores (a measure of cardiovascular health) and cancer prognosis (grouped according to the survival rates of specific cancer types) on the associations between supplement use and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>This analysis included 14,920 participants (mean age\u2009=\u200959.9\u00a0years; 60.2% female). One third (34.1%) of the participants reported using fish oil, and one fifth (20.5%) reported using glucosamine. Over a median follow-up of 12.0\u00a0years, 2,708 all-cause deaths were registered. The use of fish oil was associated with reduced risks of all-cause mortality (adjusted hazard ratio [aHR]\u2009=\u20090.89, 95% Confidence Interval [CI]\u2009=\u20090.81\u20130.97) and cancer mortality (aHR\u2009=\u20090.89, 95% CI\u2009=\u20090.81\u20130.98). Similarly, glucosamine use was associated with reduced risks of all-cause mortality (aHR\u2009=\u20090.83, 95% CI\u2009=\u20090.74\u20130.92) and cancer mortality (aHR\u2009=\u20090.83, 95% CI\u2009=\u20090.74\u20130.93) in the fully adjusted model. Subgroup analyses revealed that the protective effects of fish oil and glucosamine against mortality risk were only observed in patients with LE8 scores lower than the mean score or a poor cancer prognosis. Additionally, the association between glucosamine use and a reduced risk of CVD-related mortality was only observed in patients with lower LE8 scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This large cohort study identified the potential differential impact of LE8 scores and cancer prognosis on the associations of fish oil and glucosamine supplementation with survival in patients with cancer. This suggests the importance of considering these factors in future research on supplements and in the provision of personalized integrative cancer care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12937-024-01032-1","type":"journal-article","created":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T03:49:10Z","timestamp":1729136950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between fish oil and glucosamine use and mortality in patients diagnosed with cancer: the role of the Life Essential 8 score and cancer prognosis"],"prefix":"10.1186","volume":"23","author":[{"given":"Chun Sing","family":"Lam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Ho-Fung","family":"Loong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Chi-Ho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin Ting","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"issue":"4","key":"1032_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1200\/JCO.2007.13.5905","volume":"26","author":"CM Velicer","year":"2008","unstructured":"Velicer CM, Ulrich CM. Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol. 2008;26(4):665\u201373.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1032_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jada.2007.12.005","volume":"108","author":"MF Miller","year":"2008","unstructured":"Miller MF, Bellizzi KM, Sufian M, Ambs AH, Goldstein MS, Ballard-Barbash R. Dietary supplement use in individuals living with cancer and other chronic conditions: a population-based study. J Am Diet Assoc. 2008;108(3):483\u201394.","journal-title":"J Am Diet Assoc"},{"issue":"1","key":"1032_CR3","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1186\/s12885-017-3885-1","volume":"17","author":"S Song","year":"2017","unstructured":"Song S, Youn J, Lee YJ, Kang M, Hyun T, Song Y, et al. Dietary supplement use among cancer survivors and the general population: a nation-wide cross-sectional study. BMC Cancer. 2017;17(1):891.","journal-title":"BMC Cancer"},{"issue":"6","key":"1032_CR4","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1002\/cncr.34055","volume":"128","author":"RE Conway","year":"2022","unstructured":"Conway RE, Rigler FV, Croker HA, Lally PJ, Beeken RJ, Fisher A. Dietary supplement use by individuals living with and beyond breast, prostate, and colorectal cancer: A cross-sectional survey. Cancer. 2022;128(6):1331\u20138.","journal-title":"Cancer"},{"issue":"7","key":"1032_CR5","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00432-021-03594-7","volume":"147","author":"M Tank","year":"2021","unstructured":"Tank M, Franz K, Cereda E, Norman K. Dietary supplement use in ambulatory cancer patients: A survey on prevalence, motivation and attitudes. J Cancer Res Clin Oncol. 2021;147(7):1917\u201325.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"1032_CR6","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.3390\/nu14163402","volume":"14","author":"H Kaur","year":"2022","unstructured":"Kaur H, Hoenemeyer T, Parrish KB, Demark-Wahnefried W. Dietary supplement use among older cancer survivors: socio-demographic associations, supplement types, reasons for use, and cost. Nutrients. 2022;14(16):3402.","journal-title":"Nutrients"},{"issue":"6","key":"1032_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1089\/acm.2008.0387","volume":"15","author":"LM Ferrucci","year":"2009","unstructured":"Ferrucci LM, McCorkle R, Smith T, Stein KD, Cartmel B. Factors related to the use of dietary supplements by cancer survivors. J Altern Complement Med. 2009;15(6):673\u201380.","journal-title":"J Altern Complement Med"},{"issue":"1","key":"1032_CR8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/01635581.2020.1734215","volume":"73","author":"A Kanellopoulou","year":"2021","unstructured":"Kanellopoulou A, Riza E, Samoli E, Benetou V. Dietary supplement use after cancer diagnosis in relation to total mortality, cancer mortality and recurrence: a systematic review and meta-analysis. Nutr Cancer. 2021;73(1):16\u201330.","journal-title":"Nutr Cancer"},{"issue":"19","key":"1032_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.12968\/bjon.2018.27.19.1121","volume":"27","author":"N Griffin","year":"2018","unstructured":"Griffin N, Dowling M. Vitamin D supplementation and clinical outcomes in cancer survivorship. Br J Nurs. 2018;27(19):1121\u20138.","journal-title":"Br J Nurs"},{"issue":"8","key":"1032_CR10","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1002\/cncr.26526","volume":"118","author":"H Greenlee","year":"2012","unstructured":"Greenlee H, Kwan ML, Kushi LH, Song J, Castillo A, Weltzien E, et al. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012;118(8):2048\u201358.","journal-title":"Cancer"},{"issue":"7","key":"1032_CR11","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.ejca.2014.02.013","volume":"50","author":"HR Harris","year":"2014","unstructured":"Harris HR, Orsini N, Wolk A. Vitamin C and survival among women with breast cancer: a meta-analysis. Eur J Cancer. 2014;50(7):1223\u201331.","journal-title":"Eur J Cancer"},{"issue":"8","key":"1032_CR12","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1200\/JCO.19.01203","volume":"38","author":"CB Ambrosone","year":"2020","unstructured":"Ambrosone CB, Zirpoli GR, Hutson AD, McCann WE, McCann SE, Barlow WE, et al. Dietary supplement use during chemotherapy and survival outcomes of patients with breast cancer enrolled in a cooperative group clinical trial (SWOG S0221). J Clin Oncol. 2020;38(8):804\u201314.","journal-title":"J Clin Oncol"},{"issue":"4","key":"1032_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1002\/ijc.34321","volume":"152","author":"N Becerra-Tom\u00e1s","year":"2023","unstructured":"Becerra-Tom\u00e1s N, Balducci K, Abar L, Aune D, Cariolou M, Greenwood DC, et al. Postdiagnosis dietary factors, supplement use and breast cancer prognosis: Global Cancer Update Programme (CUP Global) systematic literature review and meta-analysis. Int J Cancer. 2023;152(4):616\u201334.","journal-title":"Int J Cancer"},{"issue":"5","key":"1032_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/annonc\/mdz059","volume":"30","author":"N Keum","year":"2019","unstructured":"Keum N, Lee D, Greenwood D, Manson J, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733\u201343.","journal-title":"Ann Oncol"},{"issue":"1","key":"1032_CR15","first-page":"17","volume":"10","author":"EJ Jacobs","year":"2001","unstructured":"Jacobs EJ, Connell CJ, Patel AV, Chao A, Rodriguez C, Seymour J, et al. Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort. Cancer Epidemiol Biomarkers Prev. 2001;10(1):17\u201323.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"1032_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tjnut.2022.12.007","volume":"153","author":"M Hauer","year":"2023","unstructured":"Hauer M, Rossi AM, Wertheim BC, Kleppel HB, Bea JW, Funk JL. Dietary Supplement Use in Women Diagnosed with Breast Cancer. J Nutr. 2023;153(1):301\u201311.","journal-title":"J Nutr"},{"issue":"6","key":"1032_CR17","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/jn\/nxaa040","volume":"150","author":"M Du","year":"2020","unstructured":"Du M, Luo H, Blumberg JB, Rogers G, Chen F, Ruan M, et al. Dietary supplement use among adult cancer survivors in the United States. J Nutr. 2020;150(6):1499\u2013508.","journal-title":"J Nutr"},{"issue":"6","key":"1032_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1136\/annrheumdis-2020-217176","volume":"79","author":"Z-H Li","year":"2020","unstructured":"Li Z-H, Gao X, Chung VC, Zhong W-F, Fu Q, Lv Y-B, et al. Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study. Ann Rheum Dis. 2020;79(6):829\u201336.","journal-title":"Ann Rheum Dis"},{"key":"1032_CR19","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s10654-012-9714-6","volume":"27","author":"GA Bell","year":"2012","unstructured":"Bell GA, Kantor ED, Lampe JW, Shen DD, White E. Use of glucosamine and chondroitin in relation to mortality. Eur J Epidemiol. 2012;27:593\u2013603.","journal-title":"Eur J Epidemiol"},{"key":"1032_CR20","doi-asserted-by":"publisher","first-page":"947818","DOI":"10.3389\/fnut.2022.947818","volume":"9","author":"J Zhou","year":"2022","unstructured":"Zhou J, Wu Z, Lin Z, Wang W, Wan R, Liu T. Association between glucosamine use and cancer mortality: A large prospective cohort study. Front Nutr. 2022;9:947818.","journal-title":"Front Nutr"},{"key":"1032_CR21","doi-asserted-by":"crossref","unstructured":"Li Z-H, Zhong W-F, Liu S, Kraus VB, Zhang Y-J, Gao X, et al. Associations of habitual fish oil supplementation with cardiovascular outcomes and all cause mortality: evidence from a large population based cohort study. BMJ. 2020;368.","DOI":"10.1136\/bmj.m456"},{"issue":"1","key":"1032_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51(1):27\u201341.","journal-title":"Immunity"},{"issue":"2","key":"1032_CR23","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s00394-015-1112-x","volume":"56","author":"N Shivappa","year":"2017","unstructured":"Shivappa N, Steck SE, Hussey JR, Ma Y, Hebert JR. Inflammatory potential of diet and all-cause, cardiovascular, and cancer mortality in National Health and Nutrition Examination Survey III Study. Eur J Nutr. 2017;56(2):683\u201392.","journal-title":"Eur J Nutr"},{"issue":"3","key":"1032_CR24","doi-asserted-by":"publisher","first-page":"e0116206","DOI":"10.1371\/journal.pone.0116206","volume":"10","author":"MJ Proctor","year":"2015","unstructured":"Proctor MJ, McMillan DC, Horgan PG, Fletcher CD, Talwar D, Morrison DS. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study. PLoS ONE. 2015;10(3):e0116206.","journal-title":"PLoS ONE"},{"key":"1032_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-nutr-071811-150726","volume":"32","author":"MJ Zhang","year":"2012","unstructured":"Zhang MJ, Spite M. Resolvins: anti-inflammatory and proresolving mediators derived from omega-3 polyunsaturated fatty acids. Annu Rev Nutr. 2012;32:203\u201327.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"1032_CR26","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.carbpol.2010.04.007","volume":"84","author":"I Nagaoka","year":"2011","unstructured":"Nagaoka I, Igarashi M, Hua J, Ju Y, Yomogida S, Sakamoto K. Recent aspects of the anti-inflammatory actions of glucosamine. Carbohydr Polym. 2011;84(2):825\u201330.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"1032_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms4563","volume":"5","author":"S Weimer","year":"2014","unstructured":"Weimer S, Priebs J, Kuhlow D, Groth M, Priebe S, Mansfeld J, et al. D-Glucosamine supplementation extends life span of nematodes and of ageing mice. Nat Commun. 2014;5(1):1\u201312.","journal-title":"Nat Commun"},{"issue":"5","key":"1032_CR28","doi-asserted-by":"publisher","first-page":"289","DOI":"10.7326\/0003-4819-153-5-201009070-00003","volume":"153","author":"TT Fung","year":"2010","unstructured":"Fung TT, van Dam RM, Hankinson SE, Stampfer M, Willett WC, Hu FB. Low-carbohydrate diets and all-cause and cause-specific mortality: two cohort studies. Ann Intern Med. 2010;153(5):289\u201398.","journal-title":"Ann Intern Med"},{"issue":"10107","key":"1032_CR29","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/S0140-6736(17)32252-3","volume":"390","author":"M Dehghan","year":"2017","unstructured":"Dehghan M, Mente A, Zhang X, Swaminathan S, Li W, Mohan V, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390(10107):2050\u201362.","journal-title":"Lancet"},{"key":"1032_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1475-2891-13-14","volume":"13","author":"A Dickinson","year":"2014","unstructured":"Dickinson A, MacKay D. Health habits and other characteristics of dietary supplement users: a review. Nutr J. 2014;13:14.","journal-title":"Nutr J"},{"issue":"12","key":"1032_CR31","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1017\/S0007114515001440","volume":"113","author":"CL Kofoed","year":"2015","unstructured":"Kofoed CL, Christensen J, Dragsted LO, Tj\u00f8nneland A, Roswall N. Determinants of dietary supplement use\u2013healthy individuals use dietary supplements. Br J Nutr. 2015;113(12):1993\u20132000.","journal-title":"Br J Nutr"},{"issue":"12","key":"1032_CR32","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1093\/jn\/128.12.2355","volume":"128","author":"BJ Lyle","year":"1998","unstructured":"Lyle BJ, Mares-Perlman JA, Klein BE, Klein R, Greger JL. Supplement users differ from nonusers in demographic, lifestyle, dietary and health characteristics. J Nutr. 1998;128(12):2355\u201362.","journal-title":"J Nutr"},{"issue":"5","key":"1032_CR33","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0000000000001078","volume":"146","author":"DM Lloyd-Jones","year":"2022","unstructured":"Lloyd-Jones DM, Allen NB, Anderson CA, Black T, Brewer LC, Foraker RE, et al. Life\u2019s essential 8: updating and enhancing the American Heart Association\u2019s construct of cardiovascular health: a presidential advisory from the American Heart Association. Circulation. 2022;146(5):e18\u201343.","journal-title":"Circulation"},{"issue":"23","key":"1032_CR34","doi-asserted-by":"publisher","first-page":"e030764","DOI":"10.1161\/JAHA.123.030764","volume":"12","author":"A Rempakos","year":"2023","unstructured":"Rempakos A, Prescott B, Mitchell GF, Vasan RS, Xanthakis V. Association of Life\u2019s Essential 8 With Cardiovascular Disease and Mortality: The Framingham Heart Study. J Am Heart Assoc. 2023;12(23):e030764.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"1032_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1200\/OP.23.00746","volume":"20","author":"P Dhakal","year":"2024","unstructured":"Dhakal P, Bhatt VR. Diet and Nutritional Supplementation in Patients With Cancer: Is More Necessarily Better? JCO oncology practice. 2024;20(3):311\u20133.","journal-title":"JCO oncology practice"},{"key":"1032_CR36","doi-asserted-by":"publisher","first-page":"l1628","DOI":"10.1136\/bmj.l1628","volume":"365","author":"H Ma","year":"2019","unstructured":"Ma H, Li X, Sun D, Zhou T, Ley SH, Gustat J, et al. Association of habitual glucosamine use with risk of cardiovascular disease: prospective study in UK Biobank. BMJ. 2019;365:l1628.","journal-title":"BMJ"},{"issue":"1","key":"1032_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0897190011406983","volume":"25","author":"BE Brinson","year":"2012","unstructured":"Brinson BE, Miller S. Fish oil: what is the role in cardiovascular health? J Pharm Pract. 2012;25(1):69\u201374.","journal-title":"J Pharm Pract"},{"issue":"15","key":"1032_CR38","doi-asserted-by":"publisher","first-page":"e867","DOI":"10.1161\/CIR.0000000000000482","volume":"135","author":"DS Siscovick","year":"2017","unstructured":"Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, et al. Omega-3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2017;135(15):e867\u201384.","journal-title":"Circulation"},{"issue":"3","key":"1032_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1001\/jamacardio.2017.5205","volume":"3","author":"T Aung","year":"2018","unstructured":"Aung T, Halsey J, Kromhout D, Gerstein HC, Marchioli R, Tavazzi L, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77 917 individuals. JAMA Cardiol. 2018;3(3):225\u201334.","journal-title":"JAMA Cardiol"},{"key":"1032_CR40","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1016\/j.biopha.2017.08.122","volume":"95","author":"F Zahedipour","year":"2017","unstructured":"Zahedipour F, Dalirfardouei R, Karimi G, Jamialahmadi K. Molecular mechanisms of anticancer effects of Glucosamine. Biomed Pharmacother. 2017;95:1051\u20138.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1032_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1080\/87559129.2019.1686761","volume":"36","author":"W Ashfaq","year":"2020","unstructured":"Ashfaq W, Rehman K, Khan QAA. Eicosapentaenoic acid and docosahexaenoic acid from fish oil and their role in cancer research. Food Rev Int. 2020;36(8):795\u2013814.","journal-title":"Food Rev Int"},{"key":"1032_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41523-020-00179-4","volume":"6","author":"K Wang","year":"2020","unstructured":"Wang K, Sun J-Z, Wu Q-X, Li Z-Y, Li D-X, Xiong Y-F, et al. Long-term anti-inflammatory diet in relation to improved breast cancer prognosis: a prospective cohort study. NPJ Breast Cancer. 2020;6:36.","journal-title":"NPJ Breast Cancer"},{"issue":"10","key":"1032_CR43","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nrclinonc.2015.105","volume":"12","author":"SM Crusz","year":"2015","unstructured":"Crusz SM, Balkwill FR. Inflammation and cancer: advances and new agents. Nat Rev Clin Oncol. 2015;12(10):584\u201396.","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"1032_CR44","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1038\/s41598-017-05278-0","volume":"7","author":"Y Shirai","year":"2017","unstructured":"Shirai Y, Okugawa Y, Hishida A, Ogawa A, Okamoto K, Shintani M, et al. Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia. Sci Rep. 2017;7(1):4826.","journal-title":"Sci Rep"},{"key":"1032_CR45","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","volume":"85","author":"E Von Elm","year":"2007","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Bull World Health Organ. 2007;85:867\u201372.","journal-title":"Bull World Health Organ"},{"key":"1032_CR46","unstructured":"UK Biobank. UK Biobank research ethics approval. 2021. https:\/\/www.ukbiobank.ac.uk\/learn-more-about-uk-biobank\/about-us\/ethics. Accessed 10 Aug 2024."},{"issue":"3","key":"1032_CR47","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12(3):e1001779.","journal-title":"PLoS Med"},{"key":"1032_CR48","unstructured":"UK Biobank. Cancer data: a report on the number of prevalent and incident cases. 2024. https:\/\/biobank.ndph.ox.ac.uk\/~bbdatan\/CancerNumbersReport.html. Accessed May 1 2024."},{"key":"1032_CR49","unstructured":"National Health Service UK. Cancer Survival in England, cancers diagnosed 2015 to 2019, followed up to 2020. 2022. https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/cancer-survival-in-england\/cancers-diagnosed-2015-to-2019-followed-up-to-2020\/survival-by-cancer-group. Accessed 1 May 2024."},{"key":"1032_CR50","unstructured":"Cancer Research UK Cancer statistics for the UK. 2022. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type. Accessed 1 May 2024."},{"issue":"9","key":"1032_CR51","doi-asserted-by":"publisher","first-page":"4497","DOI":"10.1002\/cam4.2276","volume":"8","author":"L Dal Maso","year":"2019","unstructured":"Dal Maso L, Panato C, Guzzinati S, Serraino D, Francisci S, Botta L, et al. Prognosis and cure of long-term cancer survivors: A population-based estimation. Cancer Med. 2019;8(9):4497\u2013507.","journal-title":"Cancer Med"},{"issue":"2","key":"1032_CR52","doi-asserted-by":"publisher","first-page":"pkac021","DOI":"10.1093\/jncics\/pkac021","volume":"6","author":"E Cheng","year":"2022","unstructured":"Cheng E, Lee DH, Tamimi RM, Hankinson SE, Giovannucci EL, et al. Long-term survival and causes of death after diagnoses of common cancers in 3 cohorts of US health professionals. JNCI Cancer Spectr. 2022;6(2):pkac021.","journal-title":"JNCI Cancer Spectr"},{"issue":"4","key":"1032_CR53","doi-asserted-by":"publisher","first-page":"101540","DOI":"10.1016\/j.cpcardiol.2022.101540","volume":"48","author":"F Petermann-Rocha","year":"2023","unstructured":"Petermann-Rocha F, Deo S, Celis-Morales C, Ho FK, Bahuguna P, McAllister D, et al. An opportunity for prevention: associations between the Life\u2019s Essential 8 score and cardiovascular incidence using prospective data from UK Biobank. Curr Probl Cardiol. 2023;48(4):101540.","journal-title":"Curr Probl Cardiol"},{"issue":"9","key":"1032_CR54","doi-asserted-by":"publisher","first-page":"2418","DOI":"10.1016\/j.mayocp.2021.01.036","volume":"96","author":"F Petermann-Rocha","year":"2021","unstructured":"Petermann-Rocha F, Ho FK, Foster H, Boopor J, Parra-Soto S, Gray SR, et al. Nonlinear associations between cumulative dietary risk factors and cardiovascular diseases, cancer, and all-cause mortality: a prospective cohort study from UK Biobank. Mayo Clin Pro. 2021;96(9):2418\u201331.","journal-title":"Mayo Clin Pro"},{"key":"1032_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ctcp.2019.01.004","volume":"35","author":"MR Keene","year":"2019","unstructured":"Keene MR, Heslop IM, Sabesan SS, Glass BD. Complementary and alternative medicine use in cancer: A systematic review. Complement Ther Clin Pract. 2019;35:33\u201347.","journal-title":"Complement Ther Clin Pract"},{"issue":"1","key":"1032_CR56","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1534735416660384","volume":"16","author":"PL Judson","year":"2017","unstructured":"Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther. 2017;16(1):96\u2013103.","journal-title":"Integr Cancer Ther"},{"issue":"2","key":"1032_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1017\/S0007114515001798","volume":"114","author":"MJ Bours","year":"2015","unstructured":"Bours MJ, Beijer S, Winkels RM, Van Duijnhoven FJ, Mols F, Breedveld-Peters JJ, et al. Dietary changes and dietary supplement use, and underlying motives for these habits reported by colorectal cancer survivors of the Patient Reported Outcomes Following Initial Treatment and Long-Term Evaluation of Survivorship (PROFILES) registry. Br J Nutr. 2015;114(2):286\u201396.","journal-title":"Br J Nutr"},{"issue":"4","key":"1032_CR58","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/annonc\/mdi110","volume":"16","author":"A Molassiotis","year":"2005","unstructured":"Molassiotis A, Fernadez-Ortega P, Pud D, Ozden G, Scott JA, Panteli V, et al. Use of complementary and alternative medicine in cancer patients: a European survey. Ann Oncol. 2005;16(4):655\u201363.","journal-title":"Ann Oncol"},{"issue":"5","key":"1032_CR59","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1007\/s11764-016-0530-y","volume":"10","author":"GM John","year":"2016","unstructured":"John GM, Hershman DL, Falci L, Shi Z, Tsai W-Y, Greenlee H. Complementary and alternative medicine use among US cancer survivors. J Cancer Surviv. 2016;10(5):850\u201364.","journal-title":"J Cancer Surviv"},{"key":"1032_CR60","first-page":"1","volume":"1","author":"P Posadzki","year":"2012","unstructured":"Posadzki P, Watson L, Alotaibi A, Ernst E. Prevalence of complementary and alternative medicine-use by UK cancer patients: A systematic review of surveys. Journal of Integrative Oncology. 2012;1:1.","journal-title":"Journal of Integrative Oncology"},{"issue":"5","key":"1032_CR61","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Di. 1987;40(5):373\u201383.","journal-title":"J Chronic Di"},{"issue":"3","key":"1032_CR62","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81(3):515\u201326.","journal-title":"Biometrika"},{"issue":"3","key":"1032_CR63","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.annepidem.2006.10.009","volume":"17","author":"R Li","year":"2007","unstructured":"Li R, Chambless L. Test for additive interaction in proportional hazards models. Ann Epidemiol. 2007;17(3):227\u201336.","journal-title":"Ann Epidemiol"},{"issue":"7","key":"1032_CR64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10654-005-7835-x","volume":"20","author":"T Andersson","year":"2005","unstructured":"Andersson T, Alfredsson L, K\u00e4llberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575\u20139.","journal-title":"Eur J Epidemiol"},{"issue":"2","key":"1032_CR65","first-page":"879","volume":"62","author":"CS Lam","year":"2023","unstructured":"Lam CS, Koon HK, Loong HHF, Chung VCH, Cheung YT. Associations of dietary supplement use with all-cause and cause-specific mortality in patients diagnosed with cancer: a large prospective cohort study in the UK Biobank. Eur J Nutr. 2023;62(2):879\u201389.","journal-title":"Eur J Nutr"},{"issue":"5","key":"1032_CR66","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1158\/1055-9965.EPI-13-1303","volume":"23","author":"M Inoue-Choi","year":"2014","unstructured":"Inoue-Choi M, Greenlee H, Oppeneer SJ, Robien K. The association between postdiagnosis dietary supplement use and total mortality differs by diet quality among older female cancer survivors. Cancer Epidemiol Biomarkers Prev. 2014;23(5):865\u201375.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1032_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s11764-016-0581-0","volume":"11","author":"ML Hawkins","year":"2017","unstructured":"Hawkins ML, Buys SS, Gren LH, Simonsen SE, Kirchhoff AC, Hashibe M. Do cancer survivors develop healthier lifestyle behaviors than the cancer-free population in the PLCO study? J Cancer Surviv. 2017;11(2):233\u201345.","journal-title":"J Cancer Surviv"},{"issue":"3","key":"1032_CR68","doi-asserted-by":"publisher","first-page":"e57598","DOI":"10.1371\/journal.pone.0057598","volume":"8","author":"RB Kim","year":"2013","unstructured":"Kim RB, Phillips A, Herrick K, Helou M, Rafie C, Anscher MS, et al. Physical activity and sedentary behavior of cancer survivors and non-cancer individuals: results from a national survey. PLoS ONE. 2013;8(3):e57598.","journal-title":"PLoS ONE"},{"key":"1032_CR69","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12885-015-2019-x","volume":"16","author":"IM Kanera","year":"2016","unstructured":"Kanera IM, Bolman CA, Mesters I, Willems RA, Beaulen AA, Lechner L. Prevalence and correlates of healthy lifestyle behaviors among early cancer survivors. BMC Cancer. 2016;16:4.","journal-title":"BMC Cancer"},{"issue":"7","key":"1032_CR70","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.3390\/cancers14071622","volume":"14","author":"F Guerville","year":"2022","unstructured":"Guerville F, Bourdel-Marchasson I, D\u00e9chanet-Merville J, Pellegrin I, Soubeyran P, Appay V, et al. Does inflammation contribute to cancer incidence and mortality during aging? A conceptual review. Cancers (Basel). 2022;14(7):1622.","journal-title":"Cancers (Basel)"},{"issue":"3","key":"1032_CR71","first-page":"401","volume":"10","author":"X Sun","year":"2019","unstructured":"Sun X, Xiang CJ, Wu J, Dong W, Zhan Z, Wang RP, et al. Relationship between serum inflammatory cytokines and lifestyle factors in gastric cancer. Mol Clin Oncol. 2019;10(3):401\u201314.","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"1032_CR72","doi-asserted-by":"publisher","first-page":"e0218463","DOI":"10.1371\/journal.pone.0218463","volume":"14","author":"U Nivukoski","year":"2019","unstructured":"Nivukoski U, Niemel\u00e4 M, Bloigu A, Bloigu R, Aalto M, Laatikainen T, et al. Impacts of unfavourable lifestyle factors on biomarkers of liver function, inflammation and lipid status. PLoS ONE. 2019;14(6):e0218463.","journal-title":"PLoS ONE"},{"issue":"5","key":"1032_CR73","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.numecd.2016.12.003","volume":"27","author":"E Gonz\u00e1lez-Gil","year":"2017","unstructured":"Gonz\u00e1lez-Gil E, Santab\u00e1rbara J, Ruiz J, Bel-Serrat S, Huybrechts I, Pedrero-Chamizo R, et al. Ideal cardiovascular health and inflammation in European adolescents: The HELENA study. Nutr Metab Cardiovasc Dis. 2017;27(5):447\u201355.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1032_CR74","doi-asserted-by":"crossref","unstructured":"Zheng J, Hukportie DN, Zhang Y, Huang J, Ni C, Lip GY, et al., editors. Association between glucosamine use and the risk of incident heart failure: the UK Biobank cohort study and mendelian randomization analysis. Mayo Clin Proc. 2023;98(8):1177\u201391.","DOI":"10.1016\/j.mayocp.2023.04.019"},{"issue":"15","key":"1032_CR75","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.3390\/cancers14153717","volume":"14","author":"R Zhang","year":"2022","unstructured":"Zhang R, Zhang Y, Liu Z, Pei Y, Xu P, Chong W, et al. Association between vitamin D supplementation and cancer mortality: A systematic review and meta-analysis. Cancers (Basel). 2022;14(15):3717.","journal-title":"Cancers (Basel)"},{"issue":"8","key":"1032_CR76","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/annonc\/mdm127","volume":"18","author":"M Janssen-Heijnen","year":"2007","unstructured":"Janssen-Heijnen M, Houterman S, Lemmens V, Brenner H, Steyerberg E, Coebergh J. Prognosis for long-term survivors of cancer. Ann Oncol. 2007;18(8):1408\u201313.","journal-title":"Ann Oncol"},{"issue":"9","key":"1032_CR77","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/aje\/kwx246","volume":"186","author":"A Fry","year":"2017","unstructured":"Fry A, Littlejohns TJ, Sudlow C, Doherty N, Adamska L, Sprosen T, et al. Comparison of sociodemographic and health-related characteristics of UK Biobank participants with those of the general population. Am J Epidemiol. 2017;186(9):1026\u201334.","journal-title":"Am J Epidemiol"},{"key":"1032_CR78","first-page":"m131","volume":"368","author":"GD Batty","year":"2020","unstructured":"Batty GD, Gale CR, Kivim\u00e4ki M, Deary IJ, Bell S. Comparison of risk factor associations in UK Biobank against representative, general population based studies with conventional response rates: prospective cohort study and individual participant meta-analysis. BM. 2020;368:m131.","journal-title":"BM"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-024-01032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-024-01032-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-024-01032-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T15:05:13Z","timestamp":1729177513000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-024-01032-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1186\/s12937-024-01032-1","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,17]]},"assertion":[{"value":"17 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Survey and Behavioural Research Ethics Committee of the Chinese University of Hong Kong (Reference no. SBRE-21\u20130310). The UK Biobank study was approved by the National Health Service North West Multi-centre Research Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"124"}}